Abstract: A method includes receiving an operating setpoint for an electrical power source, receiving a measurement of a voltage of an electrical bus connecting the electrical power source to an electrical receiver, comparing the measurement of the voltage with a template having limits of change over time for the voltage, and controlling the electrical power source such that if the measurement of the voltage lies within the limits of the template, the electrical power source applies the operating setpoint, and if the measurement of the voltage lies outside the limits of the template, the electrical power source regulates the voltage so as to restore the voltage to within the limits of the template. The method is implemented by a controller of the electrical power source.

Abstract: An apparatus for providing energy in an aircraft, including a DC bus; at least one low-pressure electrical source and at least one high-pressure electrical source. The apparatus further includes a system for calculating a droop gain for each electrical source, based on at least one operating characteristic of the turbine engine; and for each electrical source, a model for controlling the electrical source in question, which module is designed to implement a droop setting based on the droop gain calculated for the electrical source in question.

Abstract: A method of control of a power generation and control system of an aircraft including: a hybrid propulsion system including an electrical network and a propulsive energy source, at least one non-propulsive energy source, a control unit of the hybrid propulsion system, and an overall aircraft power control unit, characterized in that the method includes: the determination of an operability limit of the propulsive energy source, the monitoring of the operability of the propulsive energy source by the control unit of the hybrid propulsion system, and the control of a power generated by the propulsive energy source by the overall aircraft power control unit when the operability of the propulsive energy source is less than said determined operability limit or the control of a power generated by the propulsive energy source by the control unit of the hybrid propulsion system.

Abstract: A synchronous rectification alternator for a motor vehicle is disclosed. The alternator includes a stator, a rotor, and a synchronous rectification system for rectifying into a DC voltage the alternating voltages supplied by the stator, and a voltage regulator for regulating the DC voltage. The alternator also includes fault detection for detecting faults in the synchronous rectification and supplying fault detection information to the voltage regulator. In one version, the fault information is supplied to the voltage regulator at fault inputs also receiving phase signals representing the alternating voltages supplied by the stator. At least one of the items of fault information is used to cause, in the voltage regulator, opening of an excitation circuit supplying current to an excitation coil of the rotor so as to produce, in the voltage regulator, a fault indication.

Abstract: An alternator includes a stator S, a rotor R and a transistor bridge, which form synchronous rectification. The synchronous rectification is in the form of an over-molded mechatronic housing (2), and the mechatronic housing includes an electronic power substrate (3) and power connection terminals (23), (24). Electronic chips (300A, 300B) are implanted on the electronic power substrate, and at least one of the power connection terminals is connected electrically to the electronic chip by means of at least a first soldered connection wire (300, 301, 302, 30B+, 30B?). According to one embodiment, the electronic power substrate is of the IMS, DBC or PCB type.

Abstract: A synchronous rectification alternator for a motor vehicle is disclosed. The alternator includes a stator, a rotor, and a synchronous rectification system for rectifying into a DC voltage the alternating voltages supplied by the stator, and a voltage regulator for regulating the DC voltage. The alternator also includes fault detection for detecting faults in the synchronous rectification and supplying fault detection information to the voltage regulator. In one version, the fault information is supplied to the voltage regulator at fault inputs also receiving phase signals representing the alternating voltages supplied by the stator. At least one of the items of fault information is used to cause, in the voltage regulator, opening of an excitation circuit supplying current to an excitation coil of the rotor so as to produce, in the voltage regulator, a fault indication.

Abstract: An alternator includes a stator (S), a rotor (R) and a transistor bridge, which form a synchronous rectification. The synchronous rectification is in the form of an over-moulded mecatronic housing (2). The mecatronic housing includes power connection terminals (23, 24), and contains a plurality of electronic power substrates (30, 31, 32) which have the same architecture, and in each of which there is implanted at least a first electronic chip (300A, 300B) of the transistor bridge. According to one embodiment, the electronic power substrate is of the IMS, DBC or PCB type.

Abstract: An alternator includes a stator S, a rotor R and a transistor bridge, which form synchronous rectification. The synchronous rectification is in the form of an over-moulded mecatronic housing (2), and the mecatronic housing includes an electronic power substrate (3) and power connection terminals (23), (24). Electronic chips (300A, 300B) are implanted on the electronic power substrate, and at least one of the power connection terminals is connected electrically to the electronic chip by means of at least a first soldered connection wire (300, 301, 302, 30B+, 30B?). According to one embodiment, the electronic power substrate is of the IMS, DBC or PBC type.

Abstract: The invention relates to compounds having the formula (I): Wherein R1, R2, R3 and R4 are as described herein. Also disclosed are the method of preparation and their use in therapy.

Abstract: The invention relates to compounds having the formula (I): Wherein R1, R2, R3 and R4 are as described herein. Also disclosed are the method of preparation and their use in therapy.

Abstract: The invention relates to substituted 1-piperazinylacylpiperidine derivatives of general formula (I) in which: n is 1 or 2; p is 1 or 2; R1 represents a halogen atom; a trifluoromethyl radical; a (C1-C4)alkyl; a (C1-C4)alkoxy; a trifluoromethoxy radical; R2 represents a hydrogen atom or a halogen atom; R3 represents a hydrogen atom; a group —OR5; a group —CH2OR5; a group —NR6R7; a group —NR8COR9; a group —NR8CONR10R11; a group —CH2NR12R13; a group —CH2NR8CONR14R15; a (C1-C4)alkoxycarbonyl; a group —CONR16R17; or else R3 constitutes a double bond between the carbon atom to which it is attached and the adjacent carbon atom of the piperidine ring; R4 represents an aromatic group selected from: the said aromatic groups being unsubstituted or being mono- or disubstituted by a substituent selected independently from a halogen atom; a (C1-C4)alkyl; a (C1-C4)alkoxy; a trifluoromethyl radical; Preparation process and therapeutic application.

Abstract: The invention relates to substituted (4-phenylpiperazin-1-yl)acylpiperidine derivatives of formula (I) in the form of a base or an addition salt with an acid, and also in the form of a hydrate or solvate, and their preparation process and therapeutic application.

Abstract: The invention relates to substituted 1-piperazinylacylpiperidine derivatives of general formula (I) in which: n is 1 or 2; R1 represents a halogen atom; a trifluoromethyl radical; a (C1-C4) alkyl; a (C1-C4)alkoxy; a trifluoromethoxy radical; R2 represents a hydrogen atom or a halogen atom; R3 represents a hydrogen atom; a group —OR5; a group —CH2OR5; a group —NR6R7; a group —NR8COR9; a group —NR8CONR10R11; a group —CH2NR12R13; a group —CH2NR8CONR14R15; a (C1-C4)alkoxycarbonyl; a group —CONR16R17; or else R3 constitutes a double bond between the carbon atom to which it is attached and the adjacent carbon atom of the piperidine ring; R4 represents the aromatic group 1,3-thiazol-2-yl of formula: Preparation process and therapeutic application.

Abstract: The invention relates to substituted (4-phenylpiperazin-1-yl)acylpiperidine derivatives of formula (I) in the form of a base or an addition salt with an acid, and also in the form of a hydrate or solvate, and their preparation process and therapeutic application.

Abstract: The invention relates to substituted 1-piperazinylacylpiperidine derivatives of general formula (I) in which: n is 1 or 2; R1 represents a halogen atom; a trifluoromethyl radical; a (C1-C4) alkyl; a (C1-C4)alkoxy; a trifluoromethoxy radical; R2 represents a hydrogen atom or a halogen atom; R3 represents a hydrogen atom; a group —OR5; a group —CH2OR5; a group —NR6R7; a group —NR8COR9; a group —NR8CONR10R11; a group —CH2NR12R13; a group —CH2NR8CONR14R15; a (C1-C4)alkoxycarbonyl; a group —CONR16R17; or else R3 constitutes a double bond between the carbon atom to which it is attached and the adjacent carbon atom of the piperidine ring; R4 represents the aromatic group 1,3-thiazol-2-yl of formula: Preparation process and therapeutic application.

Abstract: The invention relates to novel (aminoalkenyl-benzoyl) benzofuran or benzothiophene derivatives of general formula: These compounds are of use as medicaments, in particular in the treatment of pathological syndromes of the cardiovascular system.

Abstract: The invention relates to substituted 1-piperazinylacylpiperidine derivatives of general formula (I) in which: n is 1 or 2; p is 1 or 2; R1 represents a halogen atom; a trifluoromethyl radical; a (C1-C4)alkyl; a (C1-C4)alkoxy; a trifluoromethoxy radical; R2 represents a hydrogen atom or a halogen atom; R3 represents a hydrogen atom; a group —OR5; a group —CH2OR5; a group —NR6R7; a group —NR8COR9; a group —NR8CONR10R11; a group —CH2NR12R13; a group —CH2NR8CONR14R15; a (C1-C4)alkoxycarbonyl; a group —CONR16R17; or else R3 constitutes a double bond between the carbon atom to which it is attached and the adjacent carbon atom of the piperidine ring; R4 represents an aromatic group selected from: the said aromatic groups being unsubstituted or being mono- or disubstituted by a substituent selected independently from a halogen atom; a (C1-C4)alkyl; a (C1-C4)alkoxy; a trifluoromethyl radical; Preparation process and therapeutic application.

Abstract: The invention relates to novel (aminoalkenyl-benzoyl) benzofuran or benzothiophene derivatives of general formula: 1